• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转化生长因子-β信号负调控因子PICK1抑制前列腺癌向骨转移。

The TGF-β signalling negative regulator PICK1 represses prostate cancer metastasis to bone.

作者信息

Dai Yuhu, Ren Dong, Yang Qing, Cui Yanmei, Guo Wei, Lai Yingrong, Du Hong, Lin Chuyong, Li Jun, Song Libing, Peng Xinsheng

机构信息

Department of Orthopaedic Surgery, The First Affiliated Hospital of Sun Yat-sen University, 58# Zhongshan 2rd Road, Guangzhou 510080, China.

Guangdong Provincial Key Laboratory of Orthopedics and Traumatology, 58# Zhongshan 2rd Road, Guangzhou 510080, Guangdong Province, China.

出版信息

Br J Cancer. 2017 Aug 22;117(5):685-694. doi: 10.1038/bjc.2017.212. Epub 2017 Jul 11.

DOI:10.1038/bjc.2017.212
PMID:28697177
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5572169/
Abstract

UNLABELLED

Backgroud:Constitutive activation of TGF-β signalling is a well-recognised mechanism in bone metastasis of prostate cancer (PCa). Protein Interacting with PRKCA 1 (PICK1) is a critical negative regulator of the TGF-β pathway. However, the clinical significance and biological role of PICK1 in PCa bone metastasis remain obscure.

METHODS

PICK1 expression is evaluated by immunohistochemistry (IHC) in 198 PCa patients. Statistical analysis is performed to explore correlation between PICK1 expression and clinicopathological features in PCa patients. The biological role of PICK1 is examined in PC-3 and C4-2B cells in vitro and a mouse intracardial model in vivo.

RESULTS

PICK1 expression is decreased in PCa tissues with bone metastasis and bone-derived cells and downregulation of PICK1 positively correlates with serum PSA level, Gleason grade and bone metastasis status in PCa patients. Overexpression of PICK1 suppresses PCa cell invasion and migration in vitro and bone metastasis in vivo. Our results further indicate downregulation of PICK1 is caused by miR-210-3p overexpression in PCa tissues with bone metastasis. Clinical negative correlation of PICK1 with miR-210-3p is confirmed in PCa tissues.

CONCLUSIONS

Our findings uncover a novel functionally and clinically relevant epigenetic regulatory mechanism for constitutive activation of TGF-β signalling in bone metastasis of PCa.

摘要

未标记

背景:转化生长因子-β(TGF-β)信号通路的组成性激活是前列腺癌(PCa)骨转移中一种公认的机制。与蛋白激酶Cα相互作用蛋白1(PICK1)是TGF-β信号通路的关键负调节因子。然而,PICK1在PCa骨转移中的临床意义和生物学作用仍不清楚。

方法

采用免疫组织化学(IHC)法检测198例PCa患者的PICK1表达。进行统计学分析以探讨PICK1表达与PCa患者临床病理特征之间的相关性。在体外PC-3和C4-2B细胞以及体内小鼠心内模型中研究PICK1的生物学作用。

结果

在发生骨转移的PCa组织和骨来源细胞中PICK1表达降低,PICK1的下调与PCa患者的血清前列腺特异抗原(PSA)水平、Gleason分级和骨转移状态呈正相关。PICK1的过表达在体外抑制PCa细胞的侵袭和迁移,在体内抑制骨转移。我们的结果进一步表明,在发生骨转移的PCa组织中,PICK1的下调是由miR-210-3p的过表达引起的。在PCa组织中证实了PICK1与miR-210-3p的临床负相关。

结论

我们的研究结果揭示了一种新的在功能和临床上与PCa骨转移中TGF-β信号通路组成性激活相关的表观遗传调控机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359e/5572169/53828eb14893/bjc2017212f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359e/5572169/ce5446fa5950/bjc2017212f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359e/5572169/bb05cc425077/bjc2017212f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359e/5572169/9b46958ff2ef/bjc2017212f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359e/5572169/d0428d644c43/bjc2017212f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359e/5572169/80790a431a67/bjc2017212f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359e/5572169/53828eb14893/bjc2017212f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359e/5572169/ce5446fa5950/bjc2017212f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359e/5572169/bb05cc425077/bjc2017212f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359e/5572169/9b46958ff2ef/bjc2017212f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359e/5572169/d0428d644c43/bjc2017212f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359e/5572169/80790a431a67/bjc2017212f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/359e/5572169/53828eb14893/bjc2017212f6.jpg

相似文献

1
The TGF-β signalling negative regulator PICK1 represses prostate cancer metastasis to bone.转化生长因子-β信号负调控因子PICK1抑制前列腺癌向骨转移。
Br J Cancer. 2017 Aug 22;117(5):685-694. doi: 10.1038/bjc.2017.212. Epub 2017 Jul 11.
2
Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.miR-141-3p 的下调通过激活 NF-κB 信号通路促进前列腺癌骨转移。
J Exp Clin Cancer Res. 2017 Dec 4;36(1):173. doi: 10.1186/s13046-017-0645-7.
3
Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling.ZEB1的拷贝数增加介导了与miR-33a-5p的双负反馈环,该反馈环依赖于TGF-β信号传导调节前列腺癌的上皮-间质转化和骨转移。
Theranostics. 2019 Aug 14;9(21):6063-6079. doi: 10.7150/thno.36735. eCollection 2019.
4
SMAD3/SP1 complex-mediated constitutive active loop between lncRNA PCAT7 and TGF-β signaling promotes prostate cancer bone metastasis.SMAD3/SP1 复合物介导的长链非编码 RNA PCAT7 和 TGF-β 信号之间的组成性激活环促进前列腺癌骨转移。
Mol Oncol. 2020 Apr;14(4):808-828. doi: 10.1002/1878-0261.12634. Epub 2020 Feb 8.
5
Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.致癌性 miR-210-3p 通过 NF-κB 信号通路促进前列腺癌细胞 EMT 和骨转移。
Mol Cancer. 2017 Jul 10;16(1):117. doi: 10.1186/s12943-017-0688-6.
6
Transcriptional downregulation of miR-133b by REST promotes prostate cancer metastasis to bone via activating TGF-β signaling.REST 通过下调 miR-133b 促进前列腺癌骨转移,从而激活 TGF-β 信号通路。
Cell Death Dis. 2018 Jul 13;9(7):779. doi: 10.1038/s41419-018-0807-3.
7
Downregulation of miR‑19a‑3p promotes invasion, migration and bone metastasis via activating TGF‑β signaling in prostate cancer.miR-19a-3p 的下调通过激活前列腺癌中的 TGF-β 信号通路促进侵袭、迁移和骨转移。
Oncol Rep. 2018 Jan;39(1):81-90. doi: 10.3892/or.2017.6096. Epub 2017 Nov 13.
8
Downregulation of miR‑505‑3p predicts poor bone metastasis‑free survival in prostate cancer.miR-505-3p 下调预示前列腺癌骨无转移生存不良。
Oncol Rep. 2019 Jan;41(1):57-66. doi: 10.3892/or.2018.6826. Epub 2018 Oct 25.
9
Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.miR-133a-3p 的下调通过激活 PI3K/AKT 信号通路促进前列腺癌骨转移。
J Exp Clin Cancer Res. 2018 Jul 18;37(1):160. doi: 10.1186/s13046-018-0813-4.
10
MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.微小RNA-323-3p通过直接抑制SMAD2和SMAD3抑制胰腺导管腺癌的细胞侵袭和转移。
Oncotarget. 2016 Mar 22;7(12):14912-24. doi: 10.18632/oncotarget.7482.

引用本文的文献

1
Knowledge-guided multi-level network modeling with experimental characterization identifies PRKCA as a novel biomarker and tumor suppressor triggering ferroptosis in prostate cancer.通过实验表征进行知识引导的多层次网络建模确定PRKCA为一种新型生物标志物和触发前列腺癌铁死亡的肿瘤抑制因子。
Brief Bioinform. 2025 May 1;26(3). doi: 10.1093/bib/bbaf220.
2
Bone metastases of prostate cancer: Molecular mechanisms, targeted diagnosis and targeted therapy (Review).前列腺癌骨转移:分子机制、靶向诊断与靶向治疗(综述)
Oncol Rep. 2025 Apr;53(4). doi: 10.3892/or.2025.8879. Epub 2025 Feb 21.
3
Exploring vimentin's role in breast cancer via PICK1 alternative polyadenylation and the miR-615-3p-PICK1 interaction.

本文引用的文献

1
Thymosin beta 10 is a key regulator of tumorigenesis and metastasis and a novel serum marker in breast cancer.胸腺素β10是肿瘤发生和转移的关键调节因子,也是乳腺癌中的一种新型血清标志物。
Breast Cancer Res. 2017 Feb 8;19(1):15. doi: 10.1186/s13058-016-0785-2.
2
MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells.微小 RNA-182 靶向 SMAD7 增强 TGFβ 诱导的癌细胞上皮-间充质转化和转移。
Nat Commun. 2016 Dec 20;7:13884. doi: 10.1038/ncomms13884.
3
Molecular profile of 5-fluorouracil pathway genes in colorectal carcinoma.
通过PICK1可变聚腺苷酸化和miR-615-3p-PICK1相互作用探索波形蛋白在乳腺癌中的作用。
Biofactors. 2025 Jan-Feb;51(1):e2147. doi: 10.1002/biof.2147.
4
Osteoblast-Derived ECM1 Promotes Anti-Androgen Resistance in Bone Metastatic Prostate Cancer.成骨细胞衍生的ECM1促进骨转移性前列腺癌的抗雄激素抵抗。
Adv Sci (Weinh). 2025 Jan;12(2):e2407662. doi: 10.1002/advs.202407662. Epub 2024 Nov 20.
5
PICK1 inhibits the malignancy of nasopharyngeal carcinoma and serves as a novel prognostic marker.PICK1抑制鼻咽癌的恶性程度,并作为一种新的预后标志物。
Cell Death Dis. 2024 Apr 25;15(4):294. doi: 10.1038/s41419-024-06687-6.
6
The regulatory process and practical significance of non-coding RNA in the dissemination of prostate cancer to the skeletal system.非编码RNA在前列腺癌向骨骼系统转移中的调控过程及实际意义。
Front Oncol. 2024 Mar 21;14:1358422. doi: 10.3389/fonc.2024.1358422. eCollection 2024.
7
Identification of novel molecular subtypes to improve the classification framework of nasopharyngeal carcinoma.鉴定新型分子亚型,以改进鼻咽癌的分类框架。
Br J Cancer. 2024 Apr;130(7):1176-1186. doi: 10.1038/s41416-024-02579-w. Epub 2024 Jan 27.
8
PDIA6, which is regulated by TRPM2-AS/miR-424-5p axis, promotes endometrial cancer progression via TGF-beta pathway.PDIA6 通过 TRPM2-AS/miR-424-5p 轴调控,通过 TGF-β 通路促进子宫内膜癌进展。
Cell Death Dis. 2023 Dec 14;14(12):829. doi: 10.1038/s41419-023-06297-8.
9
Secreted miR-210-3p, miR-183-5p and miR-96-5p reduce sensitivity to docetaxel in prostate cancer cells.分泌的miR-210-3p、miR-183-5p和miR-96-5p降低前列腺癌细胞对多西他赛的敏感性。
Cell Death Discov. 2023 Dec 8;9(1):445. doi: 10.1038/s41420-023-01696-4.
10
The long transcript of lncRNA TMPO-AS1 promotes bone metastases of prostate cancer by regulating the CSNK2A1/DDX3X complex in Wnt/β-catenin signaling.lncRNA TMPO-AS1的长转录本通过调节Wnt/β-连环蛋白信号通路中的CSNK2A1/DDX3X复合物促进前列腺癌的骨转移。
Cell Death Discov. 2023 Aug 5;9(1):287. doi: 10.1038/s41420-023-01585-w.
结直肠癌中5-氟尿嘧啶通路基因的分子特征
BMC Cancer. 2016 Oct 12;16(1):795. doi: 10.1186/s12885-016-2826-8.
4
N-cadherin promotes epithelial-mesenchymal transition and cancer stem cell-like traits via ErbB signaling in prostate cancer cells.N-钙黏蛋白通过ErbB信号通路促进前列腺癌细胞的上皮-间质转化和癌症干细胞样特征。
Int J Oncol. 2016 Feb;48(2):595-606. doi: 10.3892/ijo.2015.3270. Epub 2015 Nov 26.
5
Protein interacting with C kinase 1 suppresses invasion and anchorage-independent growth of astrocytic tumor cells.与C激酶1相互作用的蛋白抑制星形细胞瘤细胞的侵袭和非锚定依赖性生长。
Mol Biol Cell. 2015 Dec 15;26(25):4552-61. doi: 10.1091/mbc.E15-05-0270. Epub 2015 Oct 14.
6
Epigenetic regulation of Smad2 and Smad3 by profilin-2 promotes lung cancer growth and metastasis.原癌基因蛋白 2 通过调控 Smad2 和 Smad3 的表观遗传促进肺癌的生长和转移。
Nat Commun. 2015 Sep 10;6:8230. doi: 10.1038/ncomms9230.
7
A microRNA code for prostate cancer metastasis.一种用于前列腺癌转移的微小RNA编码。
Oncogene. 2016 Mar 3;35(9):1180-92. doi: 10.1038/onc.2015.176. Epub 2015 Jun 15.
8
The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone.转化生长因子-β信号调节因子PMEPA1抑制前列腺癌向骨转移。
Cancer Cell. 2015 Jun 8;27(6):809-21. doi: 10.1016/j.ccell.2015.04.009. Epub 2015 May 14.
9
EWI-2 negatively regulates TGF-β signaling leading to altered melanoma growth and metastasis.EWI-2负向调节转化生长因子-β信号通路,导致黑色素瘤生长和转移发生改变。
Cell Res. 2015 Mar;25(3):370-85. doi: 10.1038/cr.2015.17. Epub 2015 Feb 6.
10
PICK1 links AMPA receptor stimulation to Cdc42.PICK1将AMPA受体刺激与Cdc42联系起来。
Neurosci Lett. 2015 Jan 12;585:155-9. doi: 10.1016/j.neulet.2014.11.046. Epub 2014 Dec 2.